The program for remote monitoring of patients with hypertension and diabetes, included in the compulsory medical insurance (OMS) system from 2026, has faced a systemic failure. According to "Medvestnik," citing participants of the "ITM St. Petersburg" congress, on average, less than 700 out of 35,000 planned patients are being monitored in a region – this is only 2% of the target indicator.
The reasons for the failure are technical. Medical institutions lack staff for round-the-clock support, and patients are massively refusing to participate due to a high percentage of faulty blood pressure monitors.
One of the pilot project participants said that substandard devices undermined trust in the very idea of remote control. Currently, the platform supports any devices with a registration certificate and a remote data transmission function, but it is difficult to repair the reputational damage.
The financial losses for the regions are already evident. According to "RT Doktis," even an average subject could receive about 35 million rubles for monitoring patients with hypertension and another 6 million for diabetes. At the current pace, actual payments will amount to only 317 thousand and 25 thousand rubles, respectively.
Market participants propose a solution: outsourcing observation, renting devices, and free transfer of devices at the expense of the OMS tariff delta. However, without solving the staffing issue and improving equipment quality, it will be impossible to fulfill the Ministry of Health's plan to cover 28 million patients by 2030.